• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Optos names new chief executive officer

Article

Dunfermline, U.K.-Optos plc has appointed Thomas W. Butts as chief executive officer and a member of the board of directors.

Butts has more than 20 years of progressively senior international-level experience within the health-care sector. Most recently, he was the president and chief operating officer of IDX Systems Corp. He led the successful expansion of the IDX business, achieving more than $200 million in growth. Prior to his appointment to this position in 2004, he was president and general manager of IDX Flowcast.

Related Videos
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.